Genetic predisposition plays a role, as inheritance can make certain individuals more susceptible to developing high blood pressure. Many communities lack access to basic blood pressure monitoring devices, making early detection nearly impossible. Dr. Kelly Henning of Bloomberg Philanthropies Public Health Programmes observed that countries integrating hypertension care into universal health coverage and primary care systems are achieving measurable progress. Integrating hypertension treatment into primary healthcare systems ensures that diagnosis and management occur at the community level, where they can reach the greatest number of people. Local production of blood pressure medications offers a dual benefit: creating employment opportunities while reducing costs for patients who need these drugs for lifelong management.